Addendum: Hyperprogression and impact of tumor growth kinetics after PD1/PDL1 inhibition in head and neck squamous cell carcinoma

Oncotarget. 2022 Dec 6:13:1305. doi: 10.18632/oncotarget.28316.

¹ Department of Medical Oncology, Centre Léon Bérard, Lyon, France.
² Department of Radiology, Centre Léon Bérard, Lyon, France.
³ Department of Pathology, Centre Léon Bérard, Lyon, France.
⁴ Department of Translational Research and Innovation, Centre Léon Bérard, Lyon, France.
⁵ Department of Allergology and Clinical Immunology, CHU Lyon-Sud, Pierre-Bénite, France.
⁶ Department of Head and Neck Surgery, Hôpital Universitaire de la Croix-Rousse, Lyon, France.
⁷ Department of Head and Neck Surgery, Centre Léon Bérard, Lyon, France.

No abstract available

Publication types